Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

2.4100

+0.0300

(+1.26%)

At close: 04:00PM EDT

2.4800

+0.07

(+2.90%)

After hours:

04:48PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Simply Wall St.
Analysts Have Just Cut Their Adaptimmune Therapeutics plc (NASDAQ:ADAP) Revenue Estimates By 25%
Today is shaping up negative for Adaptimmune Therapeutics plc ( NASDAQ:ADAP ) shareholders, with the analysts...
- Berkshire Grey, Inc. (NASDAQ:BGRY) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
  Simply Wall St.
- Analysts Have Been Trimming Their Owlet, Inc. (NYSE:OWLT) Price Target After Its Latest Report
  Simply Wall St.
Newsfile
Adaptimmune Reports Second-Quarter Financial Results and Business Update
- Reaffirming financial guidance; Company funded into early 2024 -- ASCO data confirms afami-cel potential for synovial sarcoma; BLA submission on-track for Q4 2022 - - Update from signal-finding Phase 1 SURPASS trial at the September ESMO 2022 Congress - - Quarterly call to be held today, August 4, 2022, at 8:00 a.m. EDT (1:00 p.m. BST) -Philadelphia, Pennsylvania, and Oxford, United Kingdom--(Newsfile Corp. - August 4, 2022) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), ...
Simply Wall St.
Shareholders in Adaptimmune Therapeutics (NASDAQ:ADAP) are in the red if they invested five years ago
Adaptimmune Therapeutics plc ( NASDAQ:ADAP ) shareholders should be happy to see the share price up 12% in the last...

Advertisement